About Shierley Widjaja
Shierley Widjaja is a director at SRT Therapeutics.
Form D filings also name Shierley Widjaja as a director at Evida Biosciences.
Shierley Widjaja first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Shierley Widjaja in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Shierley Widjaja works with at each company, as listed on that company's latest Form D.
SRT Therapeutics, Inc. · Form D, Aug 14, 2025
RB
Rolf Benirschke
Director
BD
Brian Feagan, M.D.
Director
EP
Ed Prunchunas
Director
MW
Michael Walsh
Director
LO
Lauren Otsuki
President and Chief Executive Officer, director
Evida Biosciences Inc. · Form D, Oct 11, 2024
SG
Scott Glenn
Director
MW
Michael Walsh
President, Secretary and Chief Financial Officer, director
LO
Lauren Otsuki
Director
RB
Rolf Benirschke
Director
DW
David Wrigley
Director
BD
Brian Feagan, M.D.
Director